[Epub ahead of print] Liu W, Putnam AL, Xu -Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ TReg cells. J Exp Med 203, 1701 –1711 (2006). Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL -7 increases both thymic -dependent and thymic -independent T -cell regeneration after bone marrow transplantation. Blood 97, 1491 –1497 (2001). Mackall Cl, Fry TJ, Gress RE. Harnessing the biolo gy of IL -7 for therapeutic application. Nature Rev Immunol 11, 330 -342 (2011). Melchionda F, Fry TJ, Milliron MJ, McKirdy MA, Tagaya Y, Mackall CL. Adjuvant IL -7 or IL -15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J Clin Invest 115, 1177 –1187 (2005). Morrissey PJ, Conlon P, Braddy S, Williams DE, Namen AE, Mochizuki DY. Administration of IL -7 to mice with cyclophosphamide -induced lymphopenia accelerates lymphocyte repopulation. J Immunol 146, 1547 –1552 (1991). Nanjappa SG, Walent JH, Morre M, Suresh M. Effects of IL -7 on memory CD8 T cell homeostasis are influenced by the timing of therapy in mice. J Clin Invest 118, 1027 –1039 (2008). Park JH, Yu Q, Erman B, Appelbaum JS, Montoya -Durango D, Grimes HL, et al. Suppression of IL - 7Rα transcription by IL -7 and other prosurvival cytokines: a novel mechanism for maximizing IL -7- dependent T cell survival. Immunity 21, 289 –302 (2004). Pellegrini M, Calzascia T, Elford AR, Shahinian A, Lin AE, Dissanayake D, et al. Adj uvant IL -7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nature Med 15, 528 –536 (2009). Perales M -A, Goldberg JD, Lechner L, Koehne G, Yuan J, Papadopoulos E, Young J, Jakubowski A, Zaidi B, Gallardo H, Kend le R, Liu C, Rasalan T, Xu Y, Wolchok J, Croughs T, Morre M, Maloy M, Heller G, Van den Brink, M. Recombinant human interleukin -7 (CYT107) enhances T -cell recovery without causing graft -versus -host disease following T -cell depleted allogeneic haematopoieti c stem cell transplantation. Oral Session 5: Immunotherapy/Immune reconstitution, Annual Meeting of the European Group for Blood and Marrow Transplantation, Paris, France (April 2011). Ryan CJ , Smith MR , de Bono JS , Molina A , Logothetis CJ , de Souza P , et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med.